Understanding T cell responses to COVID-19 is essential for informing public health strategies.

Vardhana, Santosha; Baldo, Lance; Morice, William G; Wherry, E John

Vardhana, Santosha; Baldo, Lance; Morice, William G; Wherry, E John.

Afiliação

Vardhana S; Lymphoma Service, Division of Hematologic Malignancies, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Baldo L; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Morice WG; Parker Institute for Cancer Immunotherapy Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Wherry EJ; Adaptive Biotechnologies, Seattle, WA, USA.

Sci Immunol ; 7(71): eabo1303, 2022 05 20.

Article em En | MEDLINE | ID: mdl-35324269

Assuntos

COVID-19; Anticorpos Antivirais; Humanos; Saúde Pública; SARS-CoV-2; Linfócitos T

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: COVID-19 Limite: Humans Idioma: En Revista: Sci Immunol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google